Autoimmune Hepatitis
From Anvita Health Wiki
Contents |
Epidemiology
- type 1
- most common form in USA
- occurs in young women, less often postmenopausal women
- type 2
- girls or young women
- a small subset are older patients, including males with concurrent hepatitis C virus infection
Pathology
- aggressive, chronic inflammation
Clinical-manifestations
-
- most patients have chronic hepatitis & cirrhosis
- an associated autoimmune disorder is common (i.e. hypothyroidism, etc)
Laboratory
- abnormal liver function tests
- serum ALT increased
- serum AST increased
- serum bilirubin increased
- low to normal serum alkaline phosphatase
- anti-smooth muscle antibodies
- anti-actin autoantibodies (type 1)
- anti-liver- kidney microsome 1 ( anti-LKM1) antibodies (type 2)
- anti- soluble liver antigen (type 3)
- 4% have false + HCV serology by 2nd generation assay
- anti-nuclear antibody ( ANA) is usually + in high titer (> 1:320)
- anti RUVBL1 autoantibodies
- other markers ( potential): SEPSECS
- elevated serum globulins, serum IgG
- liver biopsy
Management
- delay treatment until symptomatic [1]
- type 1
- corticosteroids as initial therapy (frequent response)
- azathioprine
- sole therapy
- in conjunction with corticosteroids
- after initial favorable response to corticosteroids
- type 2
- often runs an aggressive course with fulminant hepatitis or progression to cirrhosis despite corticosteroids
More General Terms
Additional Terms
References
- Medical Knowledge Self Assessment Program (MKSAP) 11, 14, 15 American College of Physicians, Philadelphia 1998, 2006, 2009
- Autoimmune Hepatitis [1]
- National Guideline Clearinghouse Diagnosis and management of autoimmune hepatitis. ngc-guideline: [2]
